Individual risk profiling for breast cancer recurrence: towards tailored follow-up schemes

被引:14
|
作者
Kraeima, J. [1 ,2 ]
Siesling, S. [1 ,3 ]
Vliegen, I. M. H. [2 ]
Klaase, J. M. [4 ]
IJzerman, M. J. [1 ]
机构
[1] Univ Twente, Dept Hlth Technol & Serv Res HTSR, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands
[2] CTIT, CHOIR, NL-7500 AE Enschede, Netherlands
[3] Comprehens Canc Ctr Netherlands IKNL, Dept Registrat & Res, NL-3511 GD Utrecht, Netherlands
[4] Med Spectrum Twente, Dept Surg, NL-7500 KA Enschede, Netherlands
关键词
breast cancer; follow-up; locoregional recurrence; prognostic factor; personalised medicine; CLINICAL-PRACTICE GUIDELINES; CONSERVING THERAPY; TUMOR RECURRENCE; EORTC; 10801; MASTECTOMY; IMPACT; MAMMOGRAPHY; VALIDATION; CARE;
D O I
10.1038/bjc.2013.401
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Breast cancer follow-up is not tailored to the risk of locoregional recurrences (LRRs) in individual patients or as a function of time. The objective of this study was to identify prognostic factors and to estimate individual and time-dependent LRR risk rates. Methods: Prognostic factors for LRR were identified by a scoping literature review, expert consultation, and stepwise multivariate regression analysis based on 5 years of data from women diagnosed with breast cancer in the Netherlands in 2005 or 2006 (n = 17 762). Inter-patient variability was elucidated by examples of 5-year risk profiles of average-, medium-, and high-risk patients, whereby 6-month interval risks were derived from regression estimates. Results: Eight prognostic factors were identified: age, tumour size, multifocality, gradation, adjuvant chemo-, adjuvant radiation-, hormonal therapy, and triple-negative receptor status. Risk profiles of the low-, average-, and high-risk example patients showed non-uniform distribution of recurrence risks (2.9, 7.6, and 9.2%, respectively, over a 5-year period). Conclusion: Individual risk profiles differ substantially in subgroups of patients defined by prognostic factors for recurrence and over time as defined in 6-month time intervals. To tailor follow-up schedules and to optimise allocation of scarce resources, risk factors, frequency, and duration of follow-up should be taken into account.
引用
收藏
页码:866 / 871
页数:6
相关论文
共 50 条
  • [1] Individual risk profiling for breast cancer recurrence: towards tailored follow-up schemes
    J Kraeima
    S Siesling
    I M H Vliegen
    J M Klaase
    M J IJzerman
    British Journal of Cancer, 2013, 109 : 866 - 871
  • [2] Rethinking breast cancer follow-up based on individual risk and recurrence management
    De Rose, Fiorenza
    Meduri, Bruno
    De Santis, Maria Carmen
    Ferro, Antonella
    Marino, Lorenza
    Colciago, Riccardo Ray
    Gregucci, Fabiana
    Vanoni, Valentina
    Apolone, Giovanni
    Di Cosimo, Serena
    Delaloge, Suzette
    Cortes, Javier
    Curigliano, Giuseppe
    CANCER TREATMENT REVIEWS, 2022, 109
  • [3] Tailored follow-up for early breast cancer patients: A prognostic index that predicts locoregional recurrence
    van Nes, J. G. H.
    Putter, H.
    van Hezewijk, M.
    Hille, E. T. M.
    Bartelink, H.
    Collette, L.
    van de Velde, C. J. H.
    EJSO, 2010, 36 (07): : 617 - 624
  • [4] Feasibility of tailored follow-up for patients with early breast cancer
    van Hezewijk, Marjan
    Smit, Dennis J. F.
    Bastiaannet, Esther
    Scholten, Astrid N.
    Ranke, Gemma M. C.
    Kroep, Judith R.
    Marijnen, Corrie A. M.
    van de Velde, Cornelis J. H.
    BREAST, 2014, 23 (06) : 852 - 858
  • [5] Personalisation of breast cancer follow-up: a time-dependent prognostic nomogram for the estimation of annual risk of locoregional recurrence in early breast cancer patients
    Witteveen, Annemieke
    Vliegen, Ingrid M. H.
    Sonke, Gabe S.
    Klaase, Joost M.
    IJzerman, Maarten J.
    Siesling, Sabine
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 152 (03) : 627 - 636
  • [6] Opportunities for personalised follow-up in breast cancer: the gap between daily practice and recurrence risk
    Voets, Madelon M.
    Hassink, Noa S.
    Veltman, Jeroen
    Slump, Cornelis H.
    Koffijberg, Hendrik
    Siesling, Sabine
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 205 (02) : 313 - 322
  • [7] Opportunities for personalised follow-up in breast cancer: the gap between daily practice and recurrence risk
    Madelon M. Voets
    Noa S. Hassink
    Jeroen Veltman
    Cornelis H. Slump
    Hendrik Koffijberg
    Sabine Siesling
    Breast Cancer Research and Treatment, 2024, 205 : 313 - 322
  • [8] Risk-based breast cancer follow-up stratified by age
    Witteveen, Annemieke
    Otten, Jan W. M.
    Vliegen, Ingrid M. H.
    Siesling, Sabine
    Timmer, Judith B.
    IJzerman, Maarten J.
    CANCER MEDICINE, 2018, 7 (10): : 5291 - 5298
  • [9] Personalisation of breast cancer follow-up: a time-dependent prognostic nomogram for the estimation of annual risk of locoregional recurrence in early breast cancer patients
    Annemieke Witteveen
    Ingrid M. H. Vliegen
    Gabe S. Sonke
    Joost M. Klaase
    Maarten J. IJzerman
    Sabine Siesling
    Breast Cancer Research and Treatment, 2015, 152 : 627 - 636
  • [10] BETTER OVERALL SURVIVAL FOR BREAST CANCER PATIENTS BY ADDING BREAST ULTRASOUND TO FOLLOW-UP EXAMINATIONS FOR EARLY DETECTION OF LOCOREGIONAL RECURRENCE-A SURVIVAL IMPACT STUDY
    Tsai, Wan-Chen
    Wei, Hung-Kuang
    Hung, Chen-Fang
    Lin, Christopher Kwang-Jane
    Cheng, Skye Hung-Chun
    Chen, Chii-Ming
    Wang, Yong Alison
    ULTRASOUND IN MEDICINE AND BIOLOGY, 2016, 42 (09) : 2058 - 2064